Market Closed

CGTX
Cognition Therapeutics
$ 0.6798
0.52%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Cognition Therapeutics News

Latest Cognition Therapeutics Stock News & CGTX Headlines

What Makes Cognition Therapeutics (CGTX) a New Buy Stock
4 days ago | zacks.com
Cognition Therapeutics, Inc. (CGTX) Q3 2026 Earnings Call Transcript
9 days ago | seekingalpha.com
Cognition Therapeutics Q3 Earnings Call Highlights
9 days ago | marketbeat.com
Cognition Therapeutics Reports Financial Results for the Third Quarter 2026 and Provides Business Update
10 days ago | globenewswire.com
Cognition Therapeutics to Host Third Quarter 2026 Financial Results and Business Update Call on November 5, 2026
13 days ago | globenewswire.com
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
24 days ago | globenewswire.com
Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045
a month ago | globenewswire.com
Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates
3 months ago | zacks.com
Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
3 months ago | globenewswire.com
Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
4 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CGTX
Cognition Therapeutics
$ 0.6798
0.52%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago